RXO (NYSE:RXO – Get Free Report) had its price objective dropped by equities researchers at Jefferies Financial Group from $33.00 to $30.00 in a note issued to investors on Friday,Benzinga reports. The firm presently has a “buy” rating on the stock. Jefferies Financial Group’s target price indicates a potential upside of 23.66% from the company’s previous close.
Other equities analysts have also recently issued research reports about the company. The Goldman Sachs Group reiterated a “neutral” rating and set a $29.00 target price on shares of RXO in a report on Monday, November 18th. Oppenheimer reissued an “outperform” rating and issued a $31.00 target price on shares of RXO in a research report on Tuesday, September 17th. Wells Fargo & Company decreased their price target on shares of RXO from $31.00 to $28.00 and set an “equal weight” rating for the company in a research note on Tuesday, January 7th. Susquehanna cut their price objective on shares of RXO from $16.00 to $12.00 and set a “negative” rating on the stock in a research report on Tuesday, November 12th. Finally, Benchmark reaffirmed a “hold” rating on shares of RXO in a research report on Tuesday, October 15th. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $26.77.
RXO Stock Down 3.7 %
RXO (NYSE:RXO – Get Free Report) last announced its quarterly earnings results on Thursday, November 7th. The company reported $0.05 earnings per share for the quarter, beating analysts’ consensus estimates of $0.04 by $0.01. RXO had a negative net margin of 6.81% and a positive return on equity of 1.64%. The firm had revenue of $1.04 billion for the quarter, compared to analyst estimates of $956.19 million. During the same quarter in the previous year, the firm posted $0.05 earnings per share. The business’s revenue was up 6.6% on a year-over-year basis. As a group, equities analysts predict that RXO will post 0.12 EPS for the current year.
Institutional Investors Weigh In On RXO
Several hedge funds have recently bought and sold shares of the company. Wilmington Savings Fund Society FSB bought a new stake in RXO in the third quarter valued at approximately $28,000. Nomura Asset Management Co. Ltd. raised its stake in RXO by 68.7% in the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 1,400 shares of the company’s stock valued at $39,000 after acquiring an additional 570 shares during the period. GAMMA Investing LLC lifted its holdings in RXO by 40.0% during the 3rd quarter. GAMMA Investing LLC now owns 1,784 shares of the company’s stock valued at $50,000 after purchasing an additional 510 shares during the last quarter. Canada Pension Plan Investment Board bought a new position in RXO during the second quarter worth $112,000. Finally, KBC Group NV increased its holdings in shares of RXO by 28.1% in the third quarter. KBC Group NV now owns 4,055 shares of the company’s stock valued at $114,000 after purchasing an additional 890 shares during the last quarter. 92.73% of the stock is currently owned by institutional investors and hedge funds.
RXO Company Profile
RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.
Further Reading
- Five stocks we like better than RXO
- Insider Trading – What You Need to Know
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- The Most Important Warren Buffett Stock for Investors: His Own
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- What Do S&P 500 Stocks Tell Investors About the Market?
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.